Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting
- PMID: 26004569
- DOI: 10.1007/s00228-015-1867-2
Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting
Abstract
Background: New pharmacovigilance legislation allows consumers to report adverse drug reactions (ADRs) directly to competent authorities in all European Union countries. Consumer reporting is available in Portugal since July 2012. In 2013, the National Pharmacovigilance System (SNF) had received 3461 spontaneous ADR reports, of which only 1.4% (n = 50) were from consumers. Consumer reporting could be one opportunity to reduce underreporting.
Aim: The aim of this study was to describe the attitudes and knowledge of the general public regarding spontaneous reporting and the reasons and opinions that can influence consumers' ADR underreporting.
Methods: A descriptive-correlational study was performed looking for consumers' attitudes and knowledge regarding spontaneous reporting. A 6-month survey was conducted from June to November 2013 in general adult consumers from a community pharmacy in Coimbra, Portugal, who used prescribed medicines or over-the-counter (OTC) drugs. Attitudes and opinions were surveyed by personal interview in a closed-answer questionnaire using a Likert scale. Questionnaires from healthcare professionals or incomplete ones were not considered. Data were analyzed using descriptive statistics, chi-square (χ(2)) tests, and Spearman's correlation coefficients.
Results: One thousand eighty-four questionnaires were collected (response rate of 81.1%) and 948 completed were selected for analysis. Of the respondents, 44.1% never heard about SNF. Younger people and those with a higher education were significantly more likely to be aware of SNF. Only one consumer had previously reported directly an ADR. Reporting ADRs indirectly through a healthcare professional (HCP) was preferred by 62.4%. The main reasons for consumers reporting spontaneous ADR would be the severity of reactions (81.1% agreed or strongly agreed) and worries about their situation (73.4% agreed or strongly agreed). Only weak and moderate correlations were found between studied statements..
Conclusions: Consumers are more likely to do spontaneous report about severe reactions or if they are worried about the symptoms. Tailored and proactive information on ADR reporting and educational interventions on consumers could increase the number of reports from consumers in Portugal.
Similar articles
-
Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities' Views and Needs.Drug Saf. 2016 Nov;39(11):1105-1116. doi: 10.1007/s40264-016-0453-6. Drug Saf. 2016. PMID: 27581398
-
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200. Health Technol Assess. 2011. PMID: 21545758 Review.
-
The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.BMC Public Health. 2018 Dec 18;18(1):1384. doi: 10.1186/s12889-018-6285-9. BMC Public Health. 2018. PMID: 30563498 Free PMC article.
-
Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria.BMC Health Serv Res. 2019 Dec 3;19(1):926. doi: 10.1186/s12913-019-4775-9. BMC Health Serv Res. 2019. PMID: 31796034 Free PMC article.
-
ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish Systems.Drug Saf. 2015 Apr;38(4):337-47. doi: 10.1007/s40264-015-0264-1. Drug Saf. 2015. PMID: 25627832 Review.
Cited by
-
Patients' Perspectives on Adverse Drug Reaction Reporting in a Developing Country: A Case Study from Ghana.Drug Saf. 2017 Oct;40(10):911-921. doi: 10.1007/s40264-017-0563-9. Drug Saf. 2017. PMID: 28653291
-
Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities' Views and Needs.Drug Saf. 2016 Nov;39(11):1105-1116. doi: 10.1007/s40264-016-0453-6. Drug Saf. 2016. PMID: 27581398
-
Factors that influence patient and public adverse drug reaction reporting: a systematic review using the theoretical domains framework.Int J Clin Pharm. 2023 Aug;45(4):801-813. doi: 10.1007/s11096-023-01591-z. Epub 2023 May 29. Int J Clin Pharm. 2023. PMID: 37247158 Free PMC article.
-
Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK.Drug Saf. 2021 Oct;44(10):1073-1083. doi: 10.1007/s40264-021-01098-4. Epub 2021 Aug 8. Drug Saf. 2021. PMID: 34368940 Free PMC article.
-
A cross-sectional study: comparison of public perceptions of adverse drug reaction reporting and monitoring in eastern and western China.BMC Health Serv Res. 2022 Mar 8;22(1):318. doi: 10.1186/s12913-022-07720-0. BMC Health Serv Res. 2022. PMID: 35260158 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous